At this rate, before long the drug industry may not include any major firms that manufacture products marketed on both sides of the Rx and OTC divide.
J&J Rides Standalone Consumer Health Track
J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.
More from Strategy
• By
Estee Lauder Companies collaborates with Serpin Pharma to explore anti-inflammatory innovation and skin longevity, while L’Oréal Group celebrates the grand opening of North America Research & Innovation Center with ribbon cutting event.
• By
British consumer goods firm Unilever PLC announces it will replace CEO Hein Schumacher with CFO and Executive Director Fernando Fernandez 1 March.
• By
Coty Inc.’s ‘competitive moat’ against upstarts and ‘dupe” competition is a five-step strategy that includes investing in master perfumers over external suppliers and the use of ‘rare, exclusive’ ingredients in scents.
• By
L’Oréal Groupe announces company heir and 28-year Director Francoise Bettencourt Meyers plans to step down when her term expires at the end of the Annual General Meeting in April.